Hematopoietic Stem Cells Transplantation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Global Hematopoietic Stem Cell Transplantation (HSCT) Market is segmented by Type (Autologous Transplant and Allogenic Transplant), Indication (Leukemia, Lymphoproliferative Disorders, and Non-Malignant Disorders), Application (Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, and Cord Blood Transplant), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America. The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Hematopoietic Stem Cells Transplantation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Hematopoietic Stem Cells Transplantation (HSCT) Industry Overview

The hematopoietic stem cell transplantation market is consolidated and consists of a few major players, that dominate the market. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Merck KGaA, Talaris Therapeutics, Lonza Group, STEMCELL Technologies, Inc, Pluristem Therapeutics, Inc., and ScienCell Research Laboratories, Inc, among others.

Hematopoietic Stem Cells Transplantation (HSCT) Market Leaders

  1. STEMCELL Technologies, Inc.

  2. Pluristem Therapeutics, Inc.

  3. Merck KGaA

  4. ScienCell Research Laboratories, Inc.

  5. Lonza Group

  6. *Disclaimer: Major Players sorted in no particular order
HSCTM.png

Bone Marrow Transplant Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?